Inogen Inc. DEF 14A: Executive Compensation Details
Ticker: INGN · Form: DEF 14A · Filed: Mar 27, 2025 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | DEF 14A |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, sec-filing, governance
TL;DR
Inogen's 14A is out, showing exec comp details for Smith, Shabshab, Wilkinson from 2021-2024. Equity award values and vesting dates are key.
AI Summary
Inogen Inc. filed a DEF 14A with the SEC on March 27, 2025, detailing executive compensation and other corporate governance matters. The filing includes information on equity awards granted to key personnel such as Kevin R. Smith, Nabil Shabshab, and Scott Wilkinson for the fiscal years ending December 31, 2021, 2022, 2023, and 2024. Specific details on the change in fair value of equity awards and vesting dates are provided for these individuals.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting company performance and investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance, not indicating immediate financial risk.
Key Numbers
- 2021-2024 — Fiscal Years Covered (Period for which executive compensation and equity awards are detailed.)
- March 27, 2025 — Filing Date (Date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- Inogen Inc. (company) — Filer of the DEF 14A
- Kevin R. Smith (person) — Executive mentioned in compensation details
- Nabil Shabshab (person) — Executive mentioned in compensation details
- Scott Wilkinson (person) — Executive mentioned in compensation details
- 0000950170-25-045737 (dollar_amount) — Accession Number for the filing
FAQ
What is the total compensation for Nabil Shabshab in fiscal year 2023?
The provided text does not specify the total compensation for Nabil Shabshab in fiscal year 2023, but it indicates that equity awards granted and vested during that year are detailed.
What were the vesting dates for equity awards granted to Kevin R. Smith in 2022?
The filing mentions 'VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember' for 2022-01-01 to 2022-12-31, indicating that vesting dates for equity awards granted to Kevin R. Smith in 2022 are part of the detailed information.
What is the change in fair value of equity awards for Scott Wilkinson in the covered year?
The filing references 'ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember' and 'ChngInFrValO' in relation to Scott Wilkinson, suggesting details on the change in fair value of his equity awards are included.
Which fiscal year saw the most significant change in fair value of equity awards for Inogen Inc. executives?
The filing provides data points for changes in fair value for multiple fiscal years (2020-2024) for various executives, but the specific year with the most significant change is not explicitly stated in this excerpt.
What is the SIC code for Inogen Inc.?
The Standard Industrial Classification (SIC) code for Inogen Inc. is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 27, 2025 by Kevin R. Smith regarding Inogen Inc (INGN).